42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-04b-1129780
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => 1803a1c9-780f-419a-9835-47300ea9ffc5
[Document ID] => 1129780
[Document naam] => 2021-02-03 Response to CBG anti-COV Nanogam off-label.pdf
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3663666-1052663-pdo/document/VWS-WOO-04b-1129780
[Opgeschort] =>
[Definitief ID] => VWS-WOO-04b-1129780
[Status] =>
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3663666-1052663-pdo
[DocumentPublicationDate] => 3 februari 2021
[DocumentStatusCheckedDate] =>
[DocumentStatusCheckedResult] =>
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 08:43:35
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 08:43:35
)
Document: VWS-WOO-04b-1129780
Klik om te vergroten
Document correcties
Geregistreerde datum: 20210203
Geregistreerde documentnaam: 2021-02-03 Response to CBG anti-COV Nanogam off-label.pdf
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-22 23:46:51 |
| Request_Omvang openbaarmaking_documenten | 1.951 | 2025-06-22 23:46:51 |
| Request_Omvang openbaarmaking_paginas | 3.058 | 2025-06-22 23:46:51 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3663666-1052663-pdo/file/download/inventory | 2025-06-22 23:46:51 |
| document_documentName | 2021-02-03 Response to CBG anti-COV Nanogam off-label.pdf | 2025-06-22 23:46:51 |
| document_documentType | 2025-06-22 23:46:51 | |
| document_documentPublicationDate | 2021-02-03 | 2025-06-22 23:46:51 |
| document_documentNumber | VWS-WOO-04b-1129780 | 2025-06-22 23:46:51 |
| document_SectionDownloadButton | 0 | 2025-06-22 23:46:51 |
| document_SectionHTMLDataDivs | 2 | 2025-06-22 23:46:51 |
| document_SectionAbout | 1 | 2025-06-22 23:46:51 |
| About_Datum document | 3 februari 2021 | 2025-06-22 23:46:51 |
| About_Type bronbestand | PDF, 2 pagina's | 2025-06-22 23:46:51 |
| About_Type bronbestand_paginas | 2 | 2025-06-22 23:46:51 |
| About_Download als | PDF (1.1 MB) | 2025-06-22 23:46:51 |
| About_Documentnummer | 1129780 | 2025-06-22 23:46:51 |
| About_Beoordeling | Gedeeltelijke openbaarmaking | 2025-06-22 23:46:51 |
| About_Gelakte gegevens | 5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-22 23:46:51 |
| About_Gelakte gegevens_linkhref_1 | https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk5 | 2025-06-22 23:46:51 |
| About_Gelakte gegevens_linkname_1 | 5.1.2e Eerbiediging van de persoonlijke levenssfeer | 2025-06-22 23:46:51 |
| About_Gelakte gegevens_linkhref_2 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over 2021-02-03 Response to CBG anti-COV Nanogam off-label.pdf (documentnummer 1ee93813-1e7b-65ea-b1fc-35a67c9c47e6) | 2025-06-22 23:46:51 |
| About_Gelakte gegevens_linkname_2 | Laat het ons weten | 2025-06-22 23:46:51 |
| document_SectionRequest | 1 | 2025-06-22 23:46:51 |
| Request_Onderdeel van | Woo-deelbesluit aangaande Testen over de periode februari 2021 | 2025-06-22 23:46:51 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3663666-1052663-pdo | 2025-06-22 23:46:51 |
| Request_Onderdeel van_linkname_1 | Woo-deelbesluit aangaande Testen over de periode februari 2021 | 2025-06-22 23:46:51 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 11 oktober 2023 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Testen over de periode februari 2021. | 2025-06-22 23:46:51 |
| Request_Periode | Februari 2021 | 2025-06-22 23:46:51 |
| Request_Type besluit | Woo-besluit | 2025-06-22 23:46:51 |
| Request_Datum besluit | 11 oktober 2023 | 2025-06-22 23:46:51 |
| Request_Omvang openbaarmaking | 1.951 documenten, 3.058 pagina's Inventarislijst | 2025-06-22 23:46:51 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3663666-1052663-pdo/file/download/document/1ee93813-1e7b-65ea-b1fc-35a67c9c47e6 | 2025-04-20 00:55:41 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-04b-1129780.pdf | 2025-04-20 00:55:41 |
| DocumentDownload_linkname | Download (pdf, 1.1 MB) | 2025-04-20 00:55:41 |
Archiefversies (8 rijen)
Archiefrij 1 — 2025-09-08 18:23:12
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-04b-1129780.pdf
documentName: VWS-WOO-04b-1129780.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 1156848
documentCompressRatio: 0
documentDateModified: 2025-09-08 18:23:12
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-08 18:23:12
lastSeen: 2025-09-08 18:23:12
text: 1129780
Off-label use ofNanogam with anti-COVID19 antibodies—Response to
question CBG case 858779
This letter regardsaresponse totherequest forclarification from CBG on01February 2021.
Wewould like tomake aseparation between Nanogam with anti-COVID19 antibodies, theproduct that was
manufactured upon...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b6f78a4ba94c74b2a830b3a193b873697f44ea92ab2fa74bf121572cead5490b
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: folder_import_8862_9ad68e008c04a7578dc4d26719b8afa4
textDigestSHA256: 29ae6105bf34b4655221481fda8ef53b9131515eb910e0bfa57ed596be9af86f
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-04b-1129780
Archiefrij 2 — 2025-09-04 16:29:47
fromFile: VWS-WOO-3663666-1052663-pdo-1f026c98-5806-6102-84fd-65673e0af118.zip
fromFilePath: ../../archieven_files/VWS-WOO-3663666-1052663-pdo-1f026c98-5806-6102-84fd-65673e0af118.zip
documentName: VWS-WOO-04b-1129780.pdf
documentType: pdf
documentCompressedSize: 916037
documentSize: 1156848
documentCompressRatio: 79.18386858083343
documentDateModified: 2025-05-01 20:19:58
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:29:47
lastSeen: 2025-09-04 16:29:47
text: 1129780
Off-label use ofNanogam with anti-COVID19 antibodies—Response to
question CBG case 858779
This letter regardsaresponse totherequest forclarification from CBG on01February 2021.
Wewould like tomake aseparation between Nanogam with anti-COVID19 antibodies, theproduct that was
manufactured upon...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b6f78a4ba94c74b2a830b3a193b873697f44ea92ab2fa74bf121572cead5490b
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3663666-1052663-pdo-1f026c98-5806-6102-84fd-65673e0af118.zip_150
textDigestSHA256: 29ae6105bf34b4655221481fda8ef53b9131515eb910e0bfa57ed596be9af86f
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-04b-1129780
Archiefrij 3 — 2025-09-04 16:29:33
fromFile: VWS-WOO-3663666-1052663-pdo-1f019dd2-ac11-698a-86c0-fda7571a98e0.zip
fromFilePath: ../../archieven_files/VWS-WOO-3663666-1052663-pdo-1f019dd2-ac11-698a-86c0-fda7571a98e0.zip
documentName: VWS-WOO-04b-1129780.pdf
documentType: pdf
documentCompressedSize: 916037
documentSize: 1156848
documentCompressRatio: 79.18386858083343
documentDateModified: 2025-05-01 20:19:58
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:29:33
lastSeen: 2025-09-04 16:29:33
text: 1129780
Off-label use ofNanogam with anti-COVID19 antibodies—Response to
question CBG case 858779
This letter regardsaresponse totherequest forclarification from CBG on01February 2021.
Wewould like tomake aseparation between Nanogam with anti-COVID19 antibodies, theproduct that was
manufactured upon...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b6f78a4ba94c74b2a830b3a193b873697f44ea92ab2fa74bf121572cead5490b
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: VWS-WOO-3663666-1052663-pdo-1f019dd2-ac11-698a-86c0-fda7571a98e0.zip_150
textDigestSHA256: 29ae6105bf34b4655221481fda8ef53b9131515eb910e0bfa57ed596be9af86f
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-04b-1129780
Archiefrij 4 — 2025-03-21 07:58:52
fromFile: 2023.204-VWS-WOO-3663666-1052663-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.204-VWS-WOO-3663666-1052663-pdo.zip
documentName: VWS-WOO-04b-1129780.pdf
documentType: pdf
documentCompressedSize: 914218
documentSize: 1156848
documentCompressRatio: 79.02663098349998
documentDateModified: 2025-01-07 15:56:12
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-21 07:58:52
lastSeen: 2025-03-21 07:58:52
text: 1129780
Off-label use ofNanogam with anti-COVID19 antibodies—Response to
question CBG case 858779
This letter regardsaresponse totherequest forclarification from CBG on01February 2021.
Wewould like tomake aseparation between Nanogam with anti-COVID19 antibodies, theproduct that was
manufactured upon...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 29ae6105bf34b4655221481fda8ef53b9131515eb910e0bfa57ed596be9af86f
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 390236
textDigestSHA256: 29ae6105bf34b4655221481fda8ef53b9131515eb910e0bfa57ed596be9af86f
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-04b-1129780
Archiefrij 5 — 2025-03-18 09:30:26
fromFile: 2023.056-VWS-WOO-3663666-1052663-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.056-VWS-WOO-3663666-1052663-pdo.zip
documentName: VWS-WOO-04b-1129780.pdf
documentType: pdf
documentCompressedSize: 914218
documentSize: 1156848
documentCompressRatio: 79.02663098349998
documentDateModified: 2025-01-07 15:56:12
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:26
lastSeen: 2025-03-18 09:30:26
text: 1129780
Off-label use ofNanogam with anti-COVID19 antibodies—Response to
question CBG case 858779
This letter regardsaresponse totherequest forclarification from CBG on01February 2021.
Wewould like tomake aseparation between Nanogam with anti-COVID19 antibodies, theproduct that was
manufactured upon...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 29ae6105bf34b4655221481fda8ef53b9131515eb910e0bfa57ed596be9af86f
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 361062
textDigestSHA256: 29ae6105bf34b4655221481fda8ef53b9131515eb910e0bfa57ed596be9af86f
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-04b-1129780
Archiefrij 6 — 2025-02-27 09:25:06
fromFile: 2021.055-VWS-WOO-3663666-1052663-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2021.055-VWS-WOO-3663666-1052663-pdo.zip
documentName: VWS-WOO-04b-1129780.pdf
documentType: pdf
documentCompressedSize: 914218
documentSize: 1156848
documentCompressRatio: 79.02663098349998
documentDateModified: 2025-01-07 15:56:12
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:06
lastSeen: 2025-02-27 09:25:06
text: 1129780
Off-label use ofNanogam with anti-COVID19 antibodies—Response to
question CBG case 858779
This letter regardsaresponse totherequest forclarification from CBG on01February 2021.
Wewould like tomake aseparation between Nanogam with anti-COVID19 antibodies, theproduct that was
manufactured upon...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 29ae6105bf34b4655221481fda8ef53b9131515eb910e0bfa57ed596be9af86f
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 274232
textDigestSHA256: 29ae6105bf34b4655221481fda8ef53b9131515eb910e0bfa57ed596be9af86f
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-04b-1129780
Archiefrij 7 — 2025-02-18 12:18:13
fromFile: VWS-WOO-3663666-1052663-pdo-13ce7073978d57eb22e11e92aa320d9fdd57eb17e2b4a1eabcdbe20ed297422f.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\VWS-WOO-3663666-1052663-pdo-13ce7073978d57eb22e11e92aa320d9fdd57eb17e2b4a1eabcdbe20ed297422f.zip
documentName: VWS-WOO-04b-1129780.pdf
documentType: pdf
documentCompressedSize: 914218
documentSize: 1156848
documentCompressRatio: 79.02663098349998
documentDateModified: 2025-01-07 15:56:12
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:13
lastSeen: 2025-02-18 12:18:13
text: 1129780
Off-label use ofNanogam with anti-COVID19 antibodies—Response to
question CBG case 858779
This letter regardsaresponse totherequest forclarification from CBG on01February 2021.
Wewould like tomake aseparation between Nanogam with anti-COVID19 antibodies, theproduct that was
manufactured upon...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 29ae6105bf34b4655221481fda8ef53b9131515eb910e0bfa57ed596be9af86f
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 124286
textDigestSHA256: 29ae6105bf34b4655221481fda8ef53b9131515eb910e0bfa57ed596be9af86f
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-04b-1129780
Archiefrij 8 — 2025-02-18 12:18:07
fromFile: besluit-3663666-1052663-pdo-4349f656eabf22025420e8a0c6722dc28a3711f361d5ec5c2aac5afb0f69f587.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\besluit-3663666-1052663-pdo-4349f656eabf22025420e8a0c6722dc28a3711f361d5ec5c2aac5afb0f69f587.zip
documentName: VWS-WOO-04b-1129780-2021-02-03_Response_to_CBG_anti-COV_Nanogam_off-label.pdf
documentType: pdf
documentCompressedSize: 914218
documentSize: 1156848
documentCompressRatio: 79.02663098349998
documentDateModified: 2024-05-28 14:13:50
dossierReference: 3663666
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:07
lastSeen: 2025-02-18 12:18:07
text: 1129780
Off-label use ofNanogam with anti-COVID19 antibodies—Response to
question CBG case 858779
This letter regardsaresponse totherequest forclarification from CBG on01February 2021.
Wewould like tomake aseparation between Nanogam with anti-COVID19 antibodies, theproduct that was
manufactured upon...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 29ae6105bf34b4655221481fda8ef53b9131515eb910e0bfa57ed596be9af86f
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 84069
textDigestSHA256: 29ae6105bf34b4655221481fda8ef53b9131515eb910e0bfa57ed596be9af86f
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-04b-1129780
(dit is ook een speeltuin)